What is 111 Inc share price today?

111 Inc (YI) share price today is {{live_price}}.

Can Indians buy 111 Inc shares?

Yes, Indians can invest in the 111 Inc (YI) from India. With INDmoney, you can buy 111 Inc at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy 111 Inc at zero transaction cost.

How can I buy 111 Inc shares from India?

It is very easy to buy 111 Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of 111 Inc be purchased?

Yes, you can buy fractional shares of 111 Inc with INDmoney app.

What are the documents required to start investing in 111 Inc stocks?

To start investing in 111 Inc, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of 111 Inc

Today’s highest price of 111 Inc (YI) is {{1_rba_end}}. Today’s lowest price of 111 Inc (YI) is {{1_rba_st}}.

What is today's market capitalisation of 111 Inc

Today's market capitalisation of 111 Inc YI is 95.9M

What is the 52 Week High and Low Range of 111 Inc

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage 111 Inc is down from its 52 Week High?

111 Inc (YI) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage 111 Inc is up from its 52 Week low?

111 Inc (YI) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of 111 Inc?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of 111 Inc

Dr. Gang Yu is the current Chief Executive Officer (CEO) of 111 Inc.

111 Inc (YI)

$1.02

-0.1

(-8.48%)▲

Market is closed - opens 7 PM, 10 Oct 2024

Performance

$1.00
$1.09
$1.02
2.14%
Downside
Day's Volatility :8.42%
Upside
6.42%
$0.55
$2.61
$1.02
46.08%
Downside
52 Weeks Volatility :78.93%
Upside
60.92%

Returns

Period	111 Inc	Sector (Consumer Staples)	Index (Russel 2000)
3 Months	9.8%	5.2%	0.0%
6 Months	-2.61%	8.7%	0.0%
1 Year	-55.91%	21.5%	0.0%
3 Years	-80.92%	15.7%	-20.8%

Highlights

Market Capitalization	95.9M
Book Value	- $7.19
Earnings Per Share (EPS)	-0.45
Wall Street Target Price	5.96

Profit Margin	-2.25%
Operating Margin TTM	0.1%

Return On Assets TTM	-5.99%
Return On Equity TTM	-66.14%

Revenue TTM	14.7B
Revenue Per Share TTM	172.84
Quarterly Revenue Growth YOY	-1.5%
Gross Profit TTM	265.3M
EBITDA	-267.6M
Diluted Eps TTM	-0.45
Quarterly Earnings Growth YOY	0.0

EPS Estimate Current Year	0.0
EPS Estimate Next Year	0.0
EPS Estimate Current Quarter	0.0
EPS Estimate Next Quarter	0.0

Analyst Recommendation

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for 111 Inc(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 484.31%

Current $1.02

Target $5.96

Company Financials

	FY18	Y/Y Change
Revenue	259.2M	↑ 86.14%
Net Income	-55.2M	↑ 52.9%
Net Profit Margin	-21.28%	↑ 4.63%

	FY19	Y/Y Change
Revenue	563.5M	↑ 121.28%
Net Income	-70.2M	↑ 29.55%
Net Profit Margin	-12.46%	↑ 8.82%

	FY20	Y/Y Change
Revenue	1.3B	↑ 107.57%
Net Income	-70.2M	↓ 6.77%
Net Profit Margin	-5.6%	↑ 6.86%

	FY21	Y/Y Change
Revenue	2.0B	↑ 51.48%
Net Income	-104.1M	↑ 44.43%
Net Profit Margin	-5.34%	↑ 0.26%

	FY22	Y/Y Change
Revenue	1.9B	↑ 8.78%
Net Income	-58.5M	↓ 38.38%
Net Profit Margin	-3.02%	↑ 2.32%

	FY23	Y/Y Change
Revenue	2.1B	↑ 10.59%
Net Income	-55.0M	↓ 3.87%
Net Profit Margin	-2.63%	↑ 0.39%

	Q1 FY23	Q/Q Change
Revenue	504.5M	↓ 5.93%
Net Income	-8.3M	↑ 127.68%
Net Profit Margin	-1.65%	↓ 0.97%

	Q2 FY23	Q/Q Change
Revenue	511.7M	↑ 5.4%
Net Income	-13.0M	↑ 63.0%
Net Profit Margin	-2.55%	↓ 0.9%

	Q3 FY23	Q/Q Change
Revenue	563.0M	↑ 12.1%
Net Income	-28.8M	↑ 125.47%
Net Profit Margin	-5.12%	↓ 2.57%

	Q4 FY23	Q/Q Change
Revenue	494.1M	↓ 14.12%
Net Income	-1.9M	↓ 93.45%
Net Profit Margin	-0.39%	↑ 4.73%

	Q1 FY24	Q/Q Change
Revenue	475.5M	↓ 2.95%
Net Income	-1.9M	↑ 1.78%
Net Profit Margin	-0.41%	↓ 0.02%

	Q2 FY24	Q/Q Change
Revenue	472.0M	↑ 0.0%
Net Income	-1.9M	↑ 0.0%
Net Profit Margin	-0.41%	↑ 0.0%

	FY18	Y/Y Change
Total Assets	224.5M	↑ 102.57%
Total Liabilities	46.8M	↓ 27.42%

	FY19	Y/Y Change
Total Assets	229.6M	↑ 4.13%
Total Liabilities	119.2M	↑ 159.22%

	FY20	Y/Y Change
Total Assets	462.7M	↑ 87.95%
Total Liabilities	259.3M	↑ 102.76%

	FY21	Y/Y Change
Total Assets	494.0M	↑ 3.94%
Total Liabilities	360.7M	↑ 35.46%

	FY22	Y/Y Change
Total Assets	497.8M	↑ 10.43%
Total Liabilities	404.9M	↑ 23.0%

	FY23	Y/Y Change
Total Assets	432.6M	↓ 11.08%
Total Liabilities	393.9M	↓ 0.45%

	Q1 FY23	Q/Q Change
Total Assets	442.5M	↓ 5.82%
Total Liabilities	349.5M	↓ 6.87%

	Q2 FY23	Q/Q Change
Total Assets	469.2M	↑ 10.19%
Total Liabilities	425.2M	↑ 26.41%

	Q3 FY23	Q/Q Change
Total Assets	423.3M	↓ 8.09%
Total Liabilities	385.4M	↓ 7.64%

	Q4 FY23	Q/Q Change
Total Assets	409.5M	↓ 5.32%
Total Liabilities	370.4M	↓ 5.96%

	Q1 FY24	Q/Q Change
Total Assets	387.3M	↓ 4.63%
Total Liabilities	353.0M	↓ 3.88%

	Q2 FY24	Q/Q Change
Total Assets	384.5M	↑ 0.0%
Total Liabilities	350.5M	↑ 0.0%

	FY18	Y/Y Change
Operating Cash Flow	-49.8M	↑ 67.84%
Investing Cash Flow	6.5M	↓ 223.06%
Financing Cash Flow	141.2M	↑ 1865.04%

	FY19	Y/Y Change
Operating Cash Flow	-72.7M	↑ 48.74%
Investing Cash Flow	33.9M	↑ 434.65%
Financing Cash Flow	15.2M	↓ 89.01%

	FY20	Y/Y Change
Operating Cash Flow	-17.9M	↓ 77.11%
Investing Cash Flow	-49.6M	↓ 236.6%
Financing Cash Flow	163.6M	↑ 900.89%

	FY21	Y/Y Change
Operating Cash Flow	-100.8M	↑ 449.71%
Investing Cash Flow	9.4M	↓ 118.52%
Financing Cash Flow	4.3M	↓ 97.44%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-3.3M	↓ 81.35%
Investing Cash Flow	20.3M	↑ 0.0%
Financing Cash Flow	305.7K	↓ 97.32%

	Q2 FY23	Q/Q Change
Operating Cash Flow	4.9M	↓ 255.57%
Investing Cash Flow	19.5M	↑ 0.0%
Financing Cash Flow	15.4M	↑ 5142.15%

Technicals Summary

Sell

Neutral

Buy

111 Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
111 Inc	62.32%	-2.61%	-55.91%	-80.92%	-77.73%
Cardinal Health, Inc.	-0.16%	4.21%	24.13%	131.16%	148.61%
Cencora Inc	-6.65%	-7.44%	18.59%	59.61%	87.73%
Mckesson Corporation	-2.81%	-6.1%	9.59%	145.36%	274.42%
Henry Schein, Inc.	1.6%	-4.35%	-5.43%	-11.76%	12.69%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
111 Inc	NA	NA	NA	0.0	-0.66	-0.06	NA	-7.19
Cardinal Health, Inc.	32.64	32.64	0.96	7.36	0.0	0.03	0.02	-13.17
Cencora Inc	23.92	23.92	1.25	13.63	1.88	0.03	0.01	4.7
Mckesson Corporation	22.12	22.12	1.44	27.59	0.0	0.04	0.01	-13.53
Henry Schein, Inc.	25.83	25.83	1.57	4.75	0.07	0.04	NA	27.64

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
111 Inc	Buy	$95.9M	-77.73%	NA	-2.25%
Cardinal Health, Inc.	Hold	$27.2B	148.61%	32.64	0.38%
Cencora Inc	Buy	$43.3B	87.73%	23.92	0.65%
Mckesson Corporation	Buy	$64.2B	274.42%	22.12	0.94%
Henry Schein, Inc.	Hold	$8.9B	12.69%	25.83	2.82%

Insights on 111 Inc

Decreasing Revenue
Revenue is down for the last 4 quarters, 4.10B → 3.42B (in $), with an average decrease of 5.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -13.77M → -14.02M (in $), with an average decrease of 0.9% per quarter
Vs CAH
In the last 1 year, Cardinal Health, Inc. has given 24.1% return, outperforming this stock by 80.0%
Vs MCK
In the last 3 years, Mckesson Corporation has given 131.2% return, outperforming this stock by 210.2%

Institutional Holdings

JPMorgan Chase & Co
0.83%
Greenwoods Asset Management Hong Kong Ltd.
0.41%
Barclays PLC
0.39%
Bank of Montreal
0.25%
BMO Capital Markets Corp.
0.25%
Renaissance Technologies Corp
0.13%

Organization	111 Inc
Employees	1520
CEO	Dr. Gang Yu
Industry	Retail Trade

111 Inc (YI)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Decreasing Revenue

Decreasing Net Profit

Vs CAH

Vs MCK

Institutional Holdings

Company Information

Discover More

FAQs